Strikeforce Technologies Inc (OTCMKTS:SFOR) has initiated a lawsuit against Microsoft claiming that Microsoft is responsible for patent litigation. The patents involved “Multichannel device utilizing a centralized out of band authentication system”. The authentication system makes use of a number of technologies that control the granting or rejection of access to a host computer. The patents had been granted by the US Patent and Trademark Office in 2011.
Blank Rome LLP has been signed as the official law firm to assist Strikeforce in the litigation lawsuit. Blank Rome is a reputed law firm with a great reputation and having a law firm like this could mean that there is some weight to the arguments made by SFOR. Strikforce states that as per the patents, the technology is the company’s intellectual property. The CEO of Strikeforce, Mark L. Kay, expressed encouragement at acquiring the services of Blank Rome for the lawsuit. He also stated that it took years for the company to develop such a security system.
He went on to say that recent rise in cybercrimes has led to an increase in the importance and demand for the company’s patented security system. He made a special reference to the global financial and healthcare markets, which have been the main target of these attacks. Therefore it is vital that the company secures its highly valuable IP against any forms of imitation. The system had been developed by the company’s current CTO and has years of telecommunication and security experience behind its inception.
Mr. Kay also stated that Strikeforce would carry on to aggressively protecting its patents from companies that try to copy the product and/or market it for their own benefits. He went on to say that the lawsuit has especially been designed to make sure that Strikforce successfully protects its IP from prying eyes.
Strikeforce Technologies Inc (OTCMKTS:SFOR) finished the June 15 session at a share price of $0.0001, without reporting a change, despite trading 321.73 million shares during the session.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: